Jasmin NUHIC’s Post

A recent article from ORTHOWORLD Inc. highlights the surge in mergers and acquisitions focused on #digital assets in the orthopedic space. Companies are increasingly recognizing the value of integrating digital technologies into their offerings. As per the article, transactions for technology assets account for 𝟮𝟲% 𝗼𝗳 𝘁𝗵𝗲 𝗱𝗲𝗮𝗹𝘀 𝗺𝗮𝗱𝗲 𝗯𝘆 𝘁𝗵𝗲 𝘁𝗼𝗽 𝟭𝟬 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀. As we move forward as an industry, integrating digital solutions will help 𝗱𝗿𝗶𝘃𝗲 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻, 𝗶𝗺𝗽𝗿𝗼𝘃𝗲 𝗲𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝗰𝗶𝗲𝘀, 𝘀𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗲 𝗼𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀, 𝗮𝗻𝗱 𝗲𝗻𝗵𝗮𝗻𝗰𝗲 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗰𝗮𝗿𝗲. At Enhatch, we’re proud to be part of this evolution, offering digital 3D planning solutions that streamline the preoperative planning process for patient-specific solutions. We can help medical device companies, distributors, and point-of-care facilities 𝗲𝗮𝘀𝗶𝗹𝘆 𝘀𝗰𝗮𝗹𝗲 𝘁𝗵𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗼𝗳 𝗽𝗮𝘁𝗶𝗲𝗻𝘁-𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀. #3Dplanning #medtech #preoperativeplanning #orthopedics #meddev #PointOfCare #distributors https://lnkd.in/e9m4n-G8

It has been a slow year for M&A but some of the most acquisitive companies are starting to ramp up activity. Enabling technology is the busiest segment among the top 10 companies for orthopedic M&A, accounting for 26% of their transactions since 2016. Our latest chart of the month ranks companies by number of acquisitions. It includes top-tier players and a few smaller companies. #mergersandacquisitions #orthopedics

So let’s talk about the ZB acquisition of OrthoGrid. I’ve posted this was a terrific call with potential for immediate impact for anterior hip surgeons reliant on fluoroscopic guidance. It was a deficiency that was large to put it mildly. What I didn’t understand were the 2 additional applications that Edouard Saget and team had developed, one for hip preservation and one for fracture fixation. Now I think this was an incredible buy. Why? Because companies built these platforms for the big volume/$$ joint replacement markets while these other procedures technically cry for assistance to make them right. Take PAO, pelvic osteotomies born out of the German experience that truly is engineering. Creating a floating free fragment around the acetabulum and repositioning it 3 dimensionally in space. With a patient who’s body can move on the table. Or osteochondroplaasty of the femoral head/neck junction. Why do they fail? Surgical imperfection-took too much or didn’t take enough where it needed it. Crying for technologic assistance. For years and ZB knows it, invested in software to address it, and now has a tool to make it a reality. Third, fracture care. The AO group recommended using tracing paper going back to Müller to plan steps and trajectories in ORIF. How could there be so few products for this ginormous application, it’s boggled my mind. But OrthoGrid has a first level application that has synergistic potential with other ZB goodies that could be truly impactful and change surgical practice while improving outcomes. Making life better for surgeons makes life better for patients. This is what I “Rewired” for. Engagement on a different level. Consultant or Digital Opinion Leader as discussing possibilities and potential is on so many of our minds, surgeons as well as reps and industry colleagues. Absolutely fascinating, exciting days in the evolution of Orthopedics. I applaud ZB on the OrthoGrid acquisition within the context of several other smart collaborations. Any thoughts? Who else do you think has scored a big win acquisition recently. I have a few thoughts but would love to drop this puck and see how it plays. #followthebod #Bodsquad #BodPod #Orthopedics #Orthopedicsurgery #jointreplacement #medtech #medicaldevicesales Zimmer Biomet

Orthopedics Trend #17: A Shift to Long-Term Thinking Largely due to the new financial environment, startups are focusing on building substantial, enduring businesses, and avoiding the pitfalls of premature exits. A second order effect of long-term thinking is that CEOs are strategizing for financial sustainability, aiming for cash flow positivity or breakeven in a growth-aligned manner. Explore 21 more trends redefining the orthopedics landscape here - https://lnkd.in/efNSUCTi

M&A deals are at a decade-low level across medtech. Only six orthopedic acquisitions have been announced this year, far fewer than the nearly 30 deals completed in 2023. Still, noteworthy transactions have taken place. Stryker, Enovis and Smith+Nephew are among the most active companies in M&A activity. Their efforts to expand product offerings are worth noting in a landscape that’s expected to remain relatively quiet into 2025: https://lnkd.in/e6rqcVjk #orthopedics #spine #sportsmedicine #jointreplacement #trauma #marketintelligence #MergerandAcquisition #MandA #businessgrowth

Last month, the Elos Orthopedics team from the US went on a week-long expedition in collaboration with our colleagues at Klingel across Germany and Switzerland - Precisely, Rosenheim, Hölstein, and Matzingen. It was a week of fruitful discussions on how our recent merger will translate into tangible benefits to the orthopedic industry. Here's a glimpse into their experience, as recounted by Tim Turner, VP of Sales and Business Development at our Memphis site:   "We met a strong team, primed for expansion," Tim reflects. "Each facility exuded capability, with established processes and systems in place, and untapped potential waiting to be unleashed. It's exciting to see the convergence of our visions and values through collaboration, and beyond the metrics, there's a sense of kinship and collective ambition." he adds.   Throughout the week, conversations revolved around the nuances of collaboration and integration. "We delved into how we can harmonize our efforts," Tim explains. "It's not only about working together; it's about leveraging our respective strengths to propel us forward."   The integration of Elos Medtech and Klingel operations in orthopedic production paints a compelling picture. "Our processes seamlessly complement each other," Tim notes. "Through integration we're paving the way for holistic solutions that cater to the entire orthopedic manufacturing supply chain."   This collaboration means more than just operational streamlining; it signifies a strategic repositioning in the market. "With Klingel, we're not just broadening our horizons," Tim stresses. "We're reshaping our collective identity, transitioning from two entities into a unified powerhouse”. Find out more about Elos Orthopedics: https://lnkd.in/ej5WDCZY #ElosMedtech #Klingel #Orthopedics #MedicalDevices #CDMO #ContractManufacturing #Integration

Orthopedics Trend #17: A Shift to Long-Term Thinking Largely due to the new financial environment, startups are focusing on building substantial, enduring businesses, and avoiding the pitfalls of premature exits. A second order effect of long-term thinking is that CEOs are strategizing for financial sustainability, aiming for cash flow positivity or breakeven in a growth-aligned manner. Explore 21 more trends redefining the orthopedics landscape here - https://lnkd.in/g7cwPJtw

ORTHOWORLD Inc. expects M&A deal volume to hold steady this year amid the higher input costs for buyers and the relative scarcity of commercial-ready companies. However, the market is due for a rebound and could become more active sometime in 2025 as interest in #orthopedic targets remains strong. Check out our latest infographic sponsored by Intech for recent deals that are worth monitoring and a breakdown of the most active players in orthopedics in recent years: https://lnkd.in/eUw_EFUk #orthopedicsurgery #medtech #MandA #marketintelligence

Orthopedic M&A deals accelerated in 2023, according to ORTHOWORLD Inc. reporting. The jump in activity marks the first year-over-year increase since 2020, but still fell short of the 42 orthopedic transactions ORTHOWORLD tracked that year. Still, there’s reason for optimism and a livelier M&A market in the years ahead. Interest in orthopedic M&A remains strong and a few major players have with recent acquisitions: Smith & Nephew acquired CartiHeal last November to capture the company’s novel technology for regenerating cartilage in the knee. Enovis acquired Lima Corporate in January to gain addition tractions in the extremities and reconstruction segments. Stryker acquired France-based SERF in December to add to its hip replacement portfolio across Europe. Globus Medical became the second biggest player in spine — the most active M&A segment in orthopedics — when it completed its merger with NuVasive last September. restor3d acquired Conformis - acquired by restor3d last year with the goal of scaling Conformis’ portfolio of personalized orthopedic devices. ORTHOWORLD expects M&A deal volume to hold steady in 2024 amid the higher input costs for buyers and the relative scarcity of commercial-ready companies. However, the market could become more active sometime in 2025 as interest in orthopedic targets remains strong. Read the article here: https://lnkd.in/eUS5ik8C #MedicalDevices #Innovation #Acquisition

💡 The Value of Long-Term Partnerships Our Chief Commercial Operations Officer for Orthopedics, Jodie Gilmore, shares her insights on the intrinsic value of cultivating enduring partnerships and what this truly means to her and how it shapes our collective approach at Elos Medtech. For us, a long-term partnership is a synonym of trust. It means that our partners believe in our capabilities, our values, and our dedication to advancing orthopedic solutions. We, in turn, trust in the shared vision that binds us together. It's a relationship built on transparency, open communication, and a common understanding of the challenges and opportunities that define our industry. The essence of long-term partnerships at Elos Medtech lies in the synergy of shared values, trust, and a commitment to excellence. It is about being more than just suppliers or customers – it's about being integral contributors to each other's success stories. Elos Medtech, Your trusted and focused solution partner since 1923. Discover more: https://lnkd.in/dgerXfp3 #CDMO #MedicalDevices #Manufacturing #ElosMedtech #Orthopedics